| Hypoxia regulates global membrane protein endocytosis through caveolin-1 in cancer cells E Bourseau-Guilmain, JA Menard, E Lindqvist, V Indira Chandran, ... Nature communications 7 (1), 11371, 2016 | 114 | 2016 |
| Metastasis stimulation by hypoxia and acidosis-induced extracellular lipid uptake is mediated by proteoglycan-dependent endocytosis JA Menard, HC Christianson, P Kucharzewska, E Bourseau-Guilmain, ... Cancer research 76 (16), 4828-4840, 2016 | 99 | 2016 |
| Ultrasensitive immunoprofiling of plasma extracellular vesicles identifies syndecan-1 as a potential tool for minimally invasive diagnosis of glioma V Indira Chandran, C Welinder, AS Månsson, S Offer, E Freyhult, ... Clinical Cancer Research 25 (10), 3115-3127, 2019 | 86 | 2019 |
| HER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancer V Indira Chandran, S Eppenberger-Castori, T Venkatesh, KL Vine, ... Oncoscience 2 (3), 207, 2015 | 34 | 2015 |
| Anti-cancer activity of an acid-labile N-alkylisatin conjugate targeting the transferrin receptor V Indira Chandran, L Matesic, JM Locke, D Skropeta, M Ranson, KL Vine Cancer letters 316 (2), 151-156, 2012 | 31 | 2012 |
| Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics V Indira Chandran, C Welinder, K Gonçalves de Oliveira, ... Journal of Neuro-oncology 144, 477-488, 2019 | 28 | 2019 |
| Extracellular lipid loading augments hypoxic paracrine signaling and promotes glioma angiogenesis and macrophage infiltration S Offer, JA Menard, JE Pérez, KG de Oliveira, VI Chandran, ... Journal of Experimental & Clinical Cancer Research 38, 1-14, 2019 | 27 | 2019 |
| Targeting urokinase and the transferrin receptor with novel, anti-mitotic N-alkylisatin cytotoxin conjugates causes selective cancer cell death and reduces tumor growth K L Vine, V Indira Chandran, J M Locke, L Matesic, J Lee, D Skropeta, ... Current Cancer Drug Targets 12 (1), 64-73, 2012 | 24 | 2012 |
| Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness V Indira Chandran, CW Wernberg, MM Lauridsen, MK Skytthe, ... Hepatology 77 (2), 558-572, 2023 | 22 | 2023 |
| Hypoxia attenuates trastuzumab uptake and trastuzumab-emtansine (T-DM1) cytotoxicity through redistribution of phosphorylated caveolin-1 V Indira Chandran, AS Månsson, M Barbachowska, M Cerezo-Magaña, ... Molecular Cancer Research 18 (4), 644-656, 2020 | 20 | 2020 |
| Tumor antigen glycosaminoglycan modification regulates antibody-drug conjugate delivery and cytotoxicity HC Christianson, JA Menard, V Indira Chandran, E Bourseau-Guilmain, ... Oncotarget 8 (40), 66960, 2017 | 17 | 2017 |
| Improved pharmacokinetic and biodistribution properties of the selective urokinase inhibitor PAI-2 (SerpinB2) by site-specific PEGylation: implications for drug delivery KL Vine, S Lobov, V Indira Chandran, NLE Harris, M Ranson Pharmaceutical research 32, 1045-1054, 2015 | 15 | 2015 |
| The prevalence and risk factors for cognitive impairment in obesity and NAFLD CW Wernberg, LL Grønkjær, BG Jacobsen, V Indira Chandran, A Krag, ... Hepatology Communications 7 (7), 2023 | 7 | 2023 |
| Stellate cell expression of SPARC-related modular calcium-binding protein 2 is associated with human non-alcoholic fatty liver disease severity FT Larsen, D Hansen, MK Terkelsen, SM Bendixen, F Avolio, ... JHEP Reports 5 (2), 100615, 2023 | 6 | 2023 |
| Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer C Godina, V Indira Chandran, M Barbachowska, H Tryggvadottir, B Nodin, ... Translational Oncology 22, 101464, 2022 | 3 | 2022 |
| Use of smoc2 as a non biomarker for developing alcoholic or non-alcoholic steatohepatitis NJH Graversen, V Indira Chandran, FT Larsen, L Grøntved, K Ravnskjær, ... | | 2023 |
| P47 Cognitive Impairment in Obesity and NAFLD: A Cross-Sectional Study of 180 Patients With Multi-Domaine Cognitive Testing and Liver Biopsy CW Wernberg, LL Grønkjær, B Gade, V Indira Chandran, A Krag, ... Official journal of the American College of Gastroenterology| ACG 118 (9S), S31, 2023 | | 2023 |
| Cognitive impairment is frequent in obesity and not restricted to persons with biopsy-proven NAFLD C Wernberg, LL Grønkjær, BG Jacobsen, V Indira Chandran, ... Journal of Hepatology 78, THU-455, 2023 | | 2023 |
| Soluble TREM2 and PRO-C3 as efficacy of intervention markers in NASH C Wernberg, V Indira Chandran, MM Lauridsen, MK Skytthe, CD Hansen, ... Journal of Hepatology 78, 2023 | | 2023 |
| Obese patients with non-alcoholic fatty liver disease have an increase in soluble plasma CD163 and a concurrent decrease in hepatic expression of CD163 MK Skytthe, FB Pedersen, CW Wernberg, V Indira Chandran, A Krag, ... Gastro Hep Advances, 2023 | | 2023 |
